Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer

p55PIK-PI3K stimulates angiogenesis in colorectal cancer cell by activating NF-κB pathway

(2013) Guihua Wang et al.   ANGIOGENESIS

Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library

(2012) Jin Zhou et al.   BMC Medical Genomics

Blocking p55PIK signaling inhibits proliferation and induces differentiation of leukemia cells

(2012) G Wang et al.   CELL DEATH AND DIFFERENTIATION

microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer

(2012) Francesca De Santa et al.   CURRENT PHARMACEUTICAL DESIGN

miR-148b Functions as a Tumor Suppressor in Pancreatic Cancer by Targeting AMPK 1

(2012) G. Zhao et al.   MOLECULAR CANCER THERAPEUTICS

p53 mutations in cancer

(2012) Patricia A. J. Muller et al.   NATURE CELL BIOLOGY

Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer

(2011) Penny Nymark et al.   GENES CHROMOSOMES & CANCER

MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer

(2011) Yongxi Song et al.   INTERNATIONAL JOURNAL OF CANCER

A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition

(2011) Nam Hee Kim et al.   JOURNAL OF CELL BIOLOGY

p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2

(2011) Taewan Kim et al.   JOURNAL OF EXPERIMENTAL MEDICINE

MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation

(2011) Yong-Xi Song et al.   Molecular Cancer

p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs

(2011) Chun-Ju Chang et al.   NATURE CELL BIOLOGY

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening

(2009) E K O Ng et al.   GUT

A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy

(2008) J. Hu et al.   MOLECULAR CANCER THERAPEUTICS